Humanetics Corporation and Pharmaceutics International, Inc. (Pii) Announce Partnership in Support of BIO 300 Clinical Trials in COVID-19 Patients

    NEXT STORY
    Sorrento Announces FDA IND Filing Today for COVI-GUARD Neutralizing and High Potency Antibody Against SARS-CoV-2
    PREV STORY
    Biocept Expands Agreement with MultiPlan to Include COVID-19 Testing
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    RedHill Biopharma Announces New U.S. Patent for its Experimental Ebola Therapy

    TEL-AVIV, Israel and RALEIGH, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

    author_avatar
    NASDAQ Market News

    Press release Biocartis Group NV: Results of the Shareholders’ Meetings held on 8 May 2020

    author_avatar
    NASDAQ Market News

    VBL Therapeutics Announces Second Quarter 2019 Financial Results

    author_avatar
    NASDAQ Market News